P&T Portfolio: Raptiva

Article

Raptiva for treatment of adult patients (18 years or older) with chronic, moderate to severe plaque psoriasis who are candidates for systemic therapy or phototherapy

Newsletter

Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.

Subscribe Now!
Recent Videos
2 experts are featured in this series
Related Content
Q&A: Pharmacists at the Frontline of Health Literacy Challenges

Q&A: Pharmacists at the Frontline of Health Literacy Challenges

Killian Meara;Amy Howard, MS, PharmD;Laura Sahm, PhD
August 30th 2025
Article
Independent, Chain Pharmacy Turnover Reflects Retail Business Churn

Independent, Chain Pharmacy Turnover Reflects Retail Business Churn

Brian Nowosielski;Joey Mattingly, PharmD, MBA, PhD
August 30th 2025
Podcast
Influenza Vaccine Rates Increased Among Black, Hispanic Older Adults

Influenza Vaccine Rates Increased Among Black, Hispanic Older Adults

Brian Nowosielski
August 30th 2025
Article
Amplifying Technicians: Josie Quick, CPhT-Adv, CSPT, BUS

Amplifying Technicians: Josie Quick, CPhT-Adv, CSPT, BUS

Killian Meara;Taylor Watterson, PharmD, PhD;Josie Quick, CPhT-Adv, CSPT, BUS
August 30th 2025
Podcast
FDA Approves First Generic GLP-1 Liraglutide for Weight Loss

FDA Approves First Generic GLP-1 Liraglutide for Weight Loss

Ashley Gallagher
August 30th 2025
Article
FDA Approves COVID-19 Vaccines for Patients 65 Years and Older

FDA Approves COVID-19 Vaccines for Patients 65 Years and Older

Ashley Gallagher
August 30th 2025
Article
© 2025 MJH Life Sciences

All rights reserved.